SCHEMBL511168

SCHEMBL511168

O=Cc1ccc(Cl)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL51391 0.80
SCHEMBL28562831 0.77 ALDH1A1 (0.54)
SCHEMBL28576319 0.77 ALDH1A1 (0.54)
SCHEMBL28565958 0.77 ALDH1A1 (0.54)
SCHEMBL28562313 0.77 ALDH1A1 (0.54)
SCHEMBL28556905 0.77 ALDH1A1 (0.54)
SCHEMBL28571795 0.77 ALDH1A1 (0.54)
SCHEMBL28568742 0.77 ALDH1A1 (0.54)
SCHEMBL29952134 0.77 ALDH1A1 (0.46)
Methylene Chloride SCHEMBL29288141 0.76 ALDH1A1 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 342 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117843596-B Preparation method of 5-chlorofuroic acid Zhongke Guosheng (Hangzhou) Technology Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-122071445-A Aldol condensation method 中国科学院大连化学物理研究所 2026-05-22 CN claimed
CN-117843596-A Preparation method of 5-chlorofuroic acid 中科国生(杭州)科技有限公司 2024-04-09 CN claimed
EP-1546150-B1 PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES AMURA THERAPEUTICS LTD (GB) 2009-03-04 EP claimed
CN-100354276-C Biologically active compounds AMURA THERAPEUTICS LTD (GB) 2007-12-12 CN claimed
US-20060100431-A1 Biologically active compounds AMURA THERAPEUTICS LIMITED (GB) 2006-05-11 US claimed
CN-1681817-A Biologically active compounds AMURA THERAPEUTICS LTD (GB) 2005-10-12 CN claimed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP claimed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO claimed
CN-117843596-B Preparation method of 5-chlorofuroic acid Zhongke Guosheng (Hangzhou) Technology Co.,Ltd. (CN) 2026-05-26 CN disclosed
CN-122071445-A Aldol condensation method 中国科学院大连化学物理研究所 2026-05-22 CN disclosed
US-20260092045-A1 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION 2026-04-02 US disclosed
EP-3573972-B1 RORGAMMA MODULATORS AND USES THEREOF GENFIT (FR) 2026-01-14 EP disclosed
EP-4611104-A1 NON-AQUEOUS ELECTROLYTE, SODIUM-ION BATTERY CONTAINING SAME, AND ELECTRICAL APPARATUS Contemporary Amperex Technology (Hong Kong) Limited (HK) 2025-09-03 EP disclosed
US-4251524-A ANIMAL GROWTH REGULATORS BAYER AKTIENGESELLSCHAFT (DE) 1981-02-17 US disclosed
US-4200576-A CEPHALOSPORINS BAYER AKTIENGESELLSCHAFT (DE) 1980-04-29 US disclosed
US-4182762-A Dioxopiperazine derivatives suitable for use as medicaments and β-lactam antibiotic intermediates BAYER AKTIENGESELLSCHAFT (DE) 1980-01-08 US disclosed
US-4147693-A βLactam antibiotics and process for their use BAYER AKTIENGESELLSCHAFT (DE) 1979-04-03 US disclosed
US-4017313-A Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-04-12 US disclosed
US-3957810-A OPTICAL BLEACHES, FLUORESCENT DYE INTERMEDIATES TSIBIZOV JURY NIKOLAEVICH 1976-05-18 US disclosed